Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) Functionality

NCT03992443 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Chiesi business decision

Conditions

Restoration of Function to CVADs

Interventions

DRUG: CUSA-081

Sponsor

Chiesi Farmaceutici S.p.A.